94 related articles for article (PubMed ID: 10705642)
1. The comparison of microglia maturation in CNS of normal human fetuses and fetuses with Down's syndrome.
Wierzba-Bobrowicz T; Lewandowska E; Schmidt-Sidor B; Gwiazda E
Folia Neuropathol; 1999; 37(4):227-34. PubMed ID: 10705642
[TBL] [Abstract][Full Text] [Related]
2. The comparison of microglia maturation in different structures of the human nervous system.
Wierzba-Bobrowicz T; Kosno-Kruszewska E; Gwiazda E; Lechowicz W
Folia Neuropathol; 1998; 36(3):152-60. PubMed ID: 9833392
[TBL] [Abstract][Full Text] [Related]
3. A morphometric evaluation of morphological types of microglia and astroglia in human fetal mesencephalon.
Wierzba-Bobrowicz T; Lechowicz W; Kosno-Kruszewska E
Folia Neuropathol; 1997; 35(1):29-35. PubMed ID: 9161098
[TBL] [Abstract][Full Text] [Related]
4. Morphological forms and localization of microglial cells in the developing human cerebellum.
Maślińska D; Laure-Kamionowska M; Kaliszek A
Folia Neuropathol; 1998; 36(3):145-51. PubMed ID: 9833391
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of CD8/CD4 ratio in the fetal thymic parenchyme in Down's syndrome.
Tamiolakis D; Venizelos I; Kotini A; Nikolaidou S; Papadopoulos N
Acta Medica (Hradec Kralove); 2003; 46(4):179-82. PubMed ID: 14965170
[TBL] [Abstract][Full Text] [Related]
6. Altered composition of polyunsaturated fatty acyl groups in phosphoglycerides of Down's syndrome fetal brain.
Brooksbank BW; Martinez M; Balazs R
J Neurochem; 1985 Mar; 44(3):869-74. PubMed ID: 3156210
[TBL] [Abstract][Full Text] [Related]
7. Fetuses with Down's Syndrome detected by prenatal screening are more likely to abort spontaneously than fetuses with Down's Syndrome not detected by prenatal screening.
Leporrier N; Herrou M; Morello R; Leymarie P
BJOG; 2003 Jan; 110(1):18-21. PubMed ID: 12504930
[TBL] [Abstract][Full Text] [Related]
8. Neuronal target genes of the neuron-restrictive silencer factor in neurospheres derived from fetuses with Down's syndrome: a gene expression study.
Bahn S; Mimmack M; Ryan M; Caldwell MA; Jauniaux E; Starkey M; Svendsen CN; Emson P
Lancet; 2002 Jan; 359(9303):310-5. PubMed ID: 11830198
[TBL] [Abstract][Full Text] [Related]
9. Urine free beta hCG and beta core in pregnancies affected by Down's syndrome.
Spencer K; Aitken DA; Macri JN; Buchanan PD
Prenat Diagn; 1996 Jul; 16(7):605-13. PubMed ID: 8843469
[TBL] [Abstract][Full Text] [Related]
10. Dimeric inhibin A as a marker for Down's syndrome in early pregnancy.
Aitken DA; Wallace EM; Crossley JA; Swanston IA; van Pareren Y; van Maarle M; Groome NP; Macri JN; Connor JM
N Engl J Med; 1996 May; 334(19):1231-6. PubMed ID: 8606718
[TBL] [Abstract][Full Text] [Related]
11. Astroglia disturbances during development of the central nervous system in fetuses with Down's syndrome.
Zdaniuk G; Wierzba-Bobrowicz T; Szpak GM; Stępień T
Folia Neuropathol; 2011; 49(2):109-14. PubMed ID: 21845539
[TBL] [Abstract][Full Text] [Related]
12. Major histocompatibility complex class II (MHC II) expression during the development of human fetal cerebral occipital lobe, cerebellum, and hematopoietic organs.
Wierzba-Bobrowicz T; Kosno-Kruszewska E; Gwiazda E; Lechowicz W
Folia Neuropathol; 2000; 38(3):111-8. PubMed ID: 11043972
[TBL] [Abstract][Full Text] [Related]
13. Sonographic identification of second-trimester fetuses with Down's syndrome.
Benacerraf BR; Gelman R; Frigoletto FD
N Engl J Med; 1987 Nov; 317(22):1371-6. PubMed ID: 2960895
[TBL] [Abstract][Full Text] [Related]
14. Alterations of the fetal extracellular matrix in the nuchal oedema of Down's syndrome.
Brand-Saberi B; Flöel H; Christ B; Schulte-Vallentin M; Schindler H
Ann Anat; 1994 Dec; 176(6):539-47. PubMed ID: 7832286
[TBL] [Abstract][Full Text] [Related]
15. Habituation in normal and Down's syndrome fetuses.
Hepper PG; Shahidullah S
Q J Exp Psychol B; 1992 Apr; 44(3-4):305-17. PubMed ID: 1534628
[TBL] [Abstract][Full Text] [Related]
16. Log-linear allometry of fetal craniofacial growth in Down's syndrome.
Cohen SR; Corrigan ML; Bookstein FL; Trotman CA; Burdi A; Barr M
J Craniofac Surg; 1995 May; 6(3):184-9. PubMed ID: 9020687
[TBL] [Abstract][Full Text] [Related]
17. Alterations in the relative amounts of specific mRNA species in the developing human brain in Down's syndrome.
Whatley SA; Hall C; Davison AN; Lim L
Biochem J; 1984 May; 220(1):179-87. PubMed ID: 6204644
[TBL] [Abstract][Full Text] [Related]
18. Prenatal pharmacotherapy rescues brain development in a Down's syndrome mouse model.
Guidi S; Stagni F; Bianchi P; Ciani E; Giacomini A; De Franceschi M; Moldrich R; Kurniawan N; Mardon K; Giuliani A; Calzà L; Bartesaghi R
Brain; 2014 Feb; 137(Pt 2):380-401. PubMed ID: 24334313
[TBL] [Abstract][Full Text] [Related]
19. Neuroanatomy of Down's syndrome: a high-resolution MRI study.
Pinter JD; Eliez S; Schmitt JE; Capone GT; Reiss AL
Am J Psychiatry; 2001 Oct; 158(10):1659-65. PubMed ID: 11578999
[TBL] [Abstract][Full Text] [Related]
20. Major histocompatibility complex class II expression in the frontal and temporal lobes in the human fetus during development.
Wierzba-Bobrowicz T; Schmidt-Sidor B; Gwiazda E; Lechowicz W; Kosno-Kruszewska E
Folia Neuropathol; 2000; 38(2):73-7. PubMed ID: 11057039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
